Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

JAK inhibitors show promise for treating various skin diseases.

RF-based therapies might help treat hair loss.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

Herbal paste and oil extract might improve dog hair quality by retaining lipids.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The study found that steroids and tetracycline helped treat active Lichen planopilaris, and hair transplants were good for later stages.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

No treatment showed clear superiority for lichen planopilaris.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.